PMID: 26349312Sep 10, 2015Paper

Targets in anticancer research--A review

Indian Journal of Experimental Biology
B S JayashreeC M Rao

Abstract

Cancer is a complex disease characterized by a loss in the normal cell regulatory mechanisms that govern cell survival, proliferation, and differentiation. Current chemotherapeutics, as anticancer agents, are developing resistance to single drug and also to treatment therapies involving multiple drugs. Cross resistance associated with the specificity and selectivity of existing drugs has restricted the application of chemotherapy. Alternatively, these limitations have given better insight in understanding the underlying molecular mechanisms responsible for the development of various stages in cancer. In the light of this, continuous efforts are being made in order to identify and validate newer anticancer targets. This review presents some of the important targets that have been already reported, such as aromatase, farnesyl transferase, histone deacetylase, tyrosine kinase and cyclin-dependent kinase. A few molecules designed against these targets have successfully reached clinical trials. However, only limited marketed drugs are available from these classes. Besides, the review also highlights some of the other important targets and strategies that have also drawn considerable attention in the area of anticancer drug developme...Continue Reading

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

Ernst Schering Research Foundation Workshop
C D Gimmi
Expert Opinion on Drug Discovery
Hideo UchidaMasahiro Kizaki
Therapeutic Advances in Hematology
Saad A Khan, Adam D Cohen
Expert Opinion on Investigational Drugs
Michel Vulfovich, Nabil Saba
© 2021 Meta ULC. All rights reserved